New important compounds for targeted and immunotherapies for lung cancer
New important compounds for targeted and immunotherapies for lung cancer
Hot topics in pharmacy practice
Updates from a range of lung cancer studies
Large B-cell lymphoma: ZUMA-1 trial
Five practice changing shifts in oncology
Treating myelodysplastic syndromes
Updates on data and results from PROPHECY, PALOMA-3 and CHECKMATE-227
Pharmacists and precision oncology
Involving pharmacists in oral oncology treatments
Two important pancreatic studies: PRODIGE 24 and PREOPANC
Rare mutations in non small cell lung cancer
The promise of immunotherapy in head and neck, and prostate cancer
Several important studies for lung cancer
The PERSEPHONE trial: 6 months and 12 months of trastuzumab in breast cancer
Key advances in ALL and AML
Four studies about relapsed myeloma and advanced disease